Medicines Distribution Consent




440

NEW ZEALAND GAZETTE, No. 19

2 MARCH 2006

Parkedale Pharmaceuticals Inc, Rochester, Michigan, United States of America

Patheon Italia SpA, Viale G.B., Stucchi, Monza, Italy

Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland

Product:
Sifrol

Active Ingredient:
Pramipexole hydrochloride 1mg

Dosage Form:
Tablet

New Zealand Sponsor:
Boehringer Ingelheim (NZ) Limited

Manufacturers:
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany

Pfizer Pharmaceuticals LLC, Arecibo, Puerto Rico

Product:
Sifrol

Active Ingredient:
Pramipexole hydrochloride 1.5mg

Dosage Form:
Tablet

New Zealand Sponsor:
Boehringer Ingelheim (NZ) Limited

Manufacturers:
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany

Pfizer Pharmaceuticals LLC, Arecibo, Puerto Rico

Product:
Sifrol

Active Ingredient:
Pramipexole hydrochloride 125µg

Dosage Form:
Tablet

New Zealand Sponsor:
Boehringer Ingelheim (NZ) Limited

Manufacturer:
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany

Pfizer Pharmaceuticals LLC, Arecibo, Puerto Rico

Product:
Sifrol

Active Ingredient:
Pramipexole hydrochloride 250µg

Dosage Form:
Tablet

New Zealand Sponsor:
Boehringer Ingelheim (NZ) Limited

Manufacturers:
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany

Pfizer Pharmaceuticals LLC, Arecibo, Puerto Rico

Dated this 23rd day of February 2006.

GRAEME GILLESPIE, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Apo-Doxazosin

Active Ingredient:
Doxazosin mesilate 1.22mg equivalent to 1mg doxazosin

Dosage Form:
Tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer:
Apotex Inc, Weston, Ontario, Canada

Product:
Apo-Doxazosin

Active Ingredient:
Doxazosin mesilate 2.44mg equivalent to 2mg doxazosin

Dosage Form:
Tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer:
Apotex Inc, Weston, Ontario, Canada

Product:
Apo-Doxazosin

Active Ingredient:
Doxazosin mesilate 4.87mg equivalent to 4mg doxazosin

Dosage Form:
Tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer:
Apotex Inc, Weston, Ontario, Canada

Product:
Apo-Terbinafine

Active Ingredient:
Terbinafine hydrochloride 281.3mg equivalent to terbinafine 250mg

Dosage Form:
Tablet

New Zealand Sponsor:
Apotex NZ Limited

Manufacturer:
Apotex Inc, Weston, Ontario, Canada

Product:
Calcitriol-DP

Active Ingredient:
Calcitriol 0.25µg

Dosage Form:
Soft gelatin capsule



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2006, No 19


Gazette.govt.nz PDF NZ Gazette 2006, No 19





✨ LLM interpretation of page content

🏥 Consent to Distribution of Sifrol Medicines

🏥 Health & Social Welfare
23 February 2006
Medicines, Distribution, Sifrol, Pramipexole hydrochloride
  • Graeme Gillespie, Acting Deputy Director-General, Public Health

🏥 Consent to Distribution of New Medicines

🏥 Health & Social Welfare
Medicines, Distribution, Apo-Doxazosin, Apo-Terbinafine, Calcitriol-DP